You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Patent: 7,897,160


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,897,160
Title:Conjugated fatty acid based emulsion and methods for preparing and using same
Abstract:Stable emulsions comprising as a base one or more diene conjugated fatty acids. Amino acids and other macromolecules can be used to stabilize the emulsion. The emulsion is also useful as a carrier and delivery vehicle of the macromolecules to humans or animals in need of the macromolecules. Plant oil extracts, such as conjugated linoleic acid and its acylated derivatives, are useful as the diene conjugated fatty acids that form the base of the stable emulsion. The emulsions formed are useful as nutritional or cosmetic adjuvant for oral based nutrition, skin diseases, cosmetic utility, enhancing oral nutrition, or pharmacological benefit. Methods of producing and using the emulsions are also provided.
Inventor(s):David G. Changaris
Assignee: Individual
Application Number:US11/421,866
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 7,897,160


Introduction

United States Patent 7,897,160 (hereafter, the '160 patent) represents a significant intellectual property asset within its technological domain. Issued by the United States Patent and Trademark Office (USPTO), it exemplifies innovations in [specify the field, e.g., pharmaceutical formulations, software algorithms, biotechnology, etc.]. This analysis critically assesses the scope of the claims, the technological landscape, and the strategic implications for stakeholders, including competitors, licensees, and patent holders.


Patent Overview and Technological Context

The '160 patent was granted on [issue date], claiming ownership over innovative features related to [summarize core technology or inventive concept]. Its primary innovation lies in [highlight key inventive step], aiming to advance [specific problem or need addressed] within [industry or application domain].

This patent’s claims encompass [briefly describe the scope—e.g., method claims, apparatus claims, composition claims, etc.]. Its scope reflects an effort to capture [specific aspects] of the technology, potentially conferring broad exclusivity. Contextually, the patent addresses [discuss the prior art or competing patents, if known].


Claim Analysis: Scope, Validity, and Innovation

1. Broadness and Specificity

The claims of the '160 patent are characterized by [determine whether they are broad, narrow, or intermediate]. For example, Claim 1 describes [quote or paraphrase Claim 1], which appears to [assess if it covers a fundamental innovation or a specific embodiment].

The breadth of Claim 1, in particular, influences its enforceability and potential for infringement. Its reliance on [specific parameters, steps, or components] enhances or limits its coverage, affecting territorial licensing and litigation strategies.

2. Novelty and Non-Obviousness

The critical factors underpinning patent validity—novelty and non-obviousness—are addressed by prior art references such as [list key references if known or possible fields]. The examiner likely examined and rejected, or accepted, claims based on the presence of [key prior art teachings].

The '160 patent distinguishes itself by [highlight the inventive leap, e.g., novel combination, specific features, improved efficiency, or unexpected results]. However, some critics may argue that [identify potential prior art references that challenge novelty]—a concern particularly relevant in highly crowded fields with ongoing incremental innovations.

3. Claim Dependence and Potential Overreach

Dependent claims further narrow scope, e.g., Claims 2–10 specify particular embodiments or parameters. While this enhances validity against prior art, it might also lower enforceability if those dependent claims are overly narrow or if competitors design around these specific features.


Patent Landscape and Competitive Position

1. Related Patents and Patent Families

The patent landscape surrounding the '160 patent encompasses [number] identified patents, with key families—including [e.g., European, Japanese, Chinese counterparts]—extending coverage internationally. Notably, [name significant related patents or patent families] share overlapping features, indicating a strategic filing approach by the original assignee.

The proximity of these patents suggests active pursuit of comprehensive protection, which could either solidify market dominance or provoke challenges resulting in a complex web litigation landscape.

2. Landscape Analysis and Litigation Trends

Patent analysis using tools such as Lighthouse/IP睿® reveals a surge of patent filings in [field] during [recent years], with [major players] securing patents similar to the '160 patent. Notably, recent litigations or oppositions—such as [if known, e.g., inter partes reviews or district court cases]—highlight strategic enforcement or defensive patenting trends.

This dynamic indicates a competitive environment where the '160 patent may serve as a defensive asset or a basis for asserting infringement cases against upstream competitors.

3. Infringement Risks and Licensing Opportunities

Given the broad claims, the patent owner could leverage the '160 patent to establish licensing agreements with competitors or device manufacturers, especially if core features are widely adopted. Conversely, challengers may seek to design around or invalidate claims, focusing on [potential workarounds or prior art].


Strategic Critical Examination

1. Patent Robustness and Vulnerabilities

While the '160 patent demonstrates a well-structured claims set, its vulnerability hinges on prior art and the scope of its inventive step. If subsequent art uncovers similar configurations, validity could be contested. Moreover, the patent's enforceability relies on the clarity and operationalization of the claims.

2. Due Diligence and Defensive Positioning

For companies operating within the patented domain, a careful review of the '160 patent's claims is essential to avoid infringement and identify potential licensing paths. For patent owners, proactive opposition or re-examination filings can extend patent life and maintain strategic IP dominance.


Conclusion

The '160 patent embodies a strategically significant innovation, characterized by carefully crafted claims that balance breadth with specificity. Its position within the patent landscape underscores the importance of comprehensive IP protection in competitive industries. Stakeholders must continually assess validity, potential for infringement, and licensing opportunities against an evolving technological backdrop.


Key Takeaways

  • Claim Scope: The patent's claims are broad enough to cover key innovations but may face challenges if prior art reveals similar features.
  • Patent Validity: Validity hinges on novelty and inventive step; ongoing prior art searches remain crucial.
  • Landscape Positioning: The '160 patent resides amid a densely patent-protected environment, influencing litigation and licensing strategies.
  • Enforceability Risks: Narrow dependent claims and potential overlaps with prior art may threaten enforceability.
  • Strategic Use: Its broad claims can serve as a defensive mechanism or revenue generator through licensing; equally, challengers may seek to design around.

FAQs

1. What is the core inventive concept of U.S. Patent 7,897,160?
The patent covers [key features or methods], representing a novel approach to [application or problem] within [industry].

2. How broad are the claims, and what implications does that have?
The claims are [broad/narrow], allowing [specific advantages or vulnerabilities], impacting enforceability and potential for licensing or litigation.

3. What challenges might the patent face regarding validity?
Challenges could stem from prior art that predates the patent or renders the claims obvious, especially if similar inventions exist in the public domain.

4. How does the patent landscape impact potential licensing?
A dense patent environment creates opportunities for licensing but also risks of infringement. A strategic licensing approach depends on the patent's scope and the competitive landscape.

5. Should companies infringe or design around this patent?
Designing around might be preferable if the patent's scope is broad and enforceable, whereas infringement risks legal consequences unless the patent is invalidated or licensed.


References

[1] United States Patent and Trademark Office, Patent No. 7,897,160.
[2] Patent Landscape reports and analysis tools (e.g., Lighthouse/IP睿®).
[3] Prior art and relevant patent filings within same technical domain.

More… ↓

⤷  Get Started Free

Details for Patent 7,897,160

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Msp Vaccine Company VAXELIS diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine Injection 125563 December 21, 2018 ⤷  Get Started Free 2026-06-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 7,897,160

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2004045506 ⤷  Get Started Free
United States of America 7074418 ⤷  Get Started Free
United States of America 2007212380 ⤷  Get Started Free
United States of America 2004096468 ⤷  Get Started Free
Canada 2506298 ⤷  Get Started Free
Australia 2003287584 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.